1 / 34

Preterm labor

Preterm labor. Outpatient considerations Joseph Breuner 2/14/06. Teaching points. Examine the cervix in 2 nd /3 rd tri patients with symptoms differentiate high risk from low risk consider using fetal fibronectin and cervical length from your clinic. Preterm birth.

soo
Télécharger la présentation

Preterm labor

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Preterm labor Outpatient considerations Joseph Breuner 2/14/06

  2. Teaching points • Examine the cervix in 2nd/3rd tri patients with symptoms • differentiate high risk from low risk • consider using fetal fibronectin and cervical length from your clinic

  3. Preterm birth • Definition: WHO birth between 20 and 37 wks • US incidence 11%, europe 5-7% • has not declined over 40 yrs

  4. Preterm birth • leading cause of neonatal mortality • 60-80% of deaths of infants without congenital anomalies

  5. Preterm labor • Definition: regular contractions and cervical change prior to 37 wks • accounts for 40-50% of preterm birth • 40% of preterm birth is PPROM • 15-20% obstetrically indicated inductions

  6. Preterm labor • 4 basic causes • infection • bleeding/abruption/thrombophilia • incompetent cervix • Multiple gestation • Note that the first two are also most common causes of PPROM

  7. Preterm labor • Infection • Clinical chorio complicates 2-5% of all pregnancies, but 25% of preterm births • Histological chorio in 10% of term births but 32% of preterm births • Goldenberg, robert, the management of preterm labor. J Obstet Gynecol 2002: 100:1020-37

  8. Preterm labor • Infection • Watts et al: of women in preterm labor, positive amniotic fluid cultures found in 19% despite no clinical signs of chorioamnionitis • Goldenberg, robert, the management of preterm labor. J Obstet Gynecol 2002: 100:1020-37

  9. Preterm labor • Infection • Proportionately more important at early gestational ages • Chorioamnion colonization associated with 83% of very early spontaneous preterm births, but much less important 28-32 or 32-37 wks • Goldenberg, robert, the management of preterm labor. J Obstet Gynecol 2002: 100:1020-37

  10. Preterm labor • Bleeding/abruption/thrombophilia • 1st tri hematoma by US increases RR of preterm birth to 2.3—nagy, et al • Inherited thrombophilias markedly increase risk of maternal thromboembolism and 2nd/3rd tri loss, but not 1st tri loss-lockwood, et al

  11. Preterm labor • ACOG practice bulletin 2003 clinical considerations and recommendations

  12. Preterm labor • Recommendations based on good and consistent scientific evidence (level A) • There are no clear ‘first-line’ tocolytic drugs to manage preterm labor. Clinical circumstances and physician preferences should dictate treatment • Acog practice bulletin, no. 43, may 2003, management of preterm labor

  13. Preterm labor • Recommendations based on good and consistent scientific evidence (level A) • Antibiotics do not appear to prolong gestation and should be reserved for group B streptococcal prophylaxis in patients in whom delivery is imminent • Acog practice bulletin, no. 43, may 2003, management of preterm labor

  14. Preterm labor • Recommendations based on good and consistent scientific evidence (level A) • Neither maintenance treatment with tocolytic drugs nor repeated acute tocolysis improve perinatal outcome; neither should be undertaken as a general practice. • Acog practice bulletin, no. 43, may 2003, management of preterm labor

  15. Preterm labor • Recommendations based on good and consistent scientific evidence (level A) • Tocolytic drugs may prolong pregnancy for 2-7 days, which may allow for administration of steroids to improve fetal lung maturity and the consideration of maternal transport to a tertiary care facility. • Acog practice bulletin, no. 43, may 2003, management of preterm labor

  16. Preterm labor • Recommendations based on limited or inconsistent scientific evidence (level B) • Cervical ultrasound examination and fetal fibronectin testing have good negative predictive value; thus, either approach or both combined may be helpful in determining which patients do not need tocolysis • Acog practice bulletin, no. 43, may 2003, management of preterm labor

  17. Preterm labor • Recommendations based on limited or inconsistent scientific evidence (level B) • Amniocentesis may be used in women in preterm labor to assess fetal lung maturity and intraamniotic infection. • Acog practice bulletin, no. 43, may 2003, management of preterm labor

  18. Preterm labor • Recommendations based on limited or inconsistent scientific evidence (level B) • Bed rest, hydration, and pelvic rest do not appear to improve the rate of preterm birth and should not be routinely recommended. • Acog practice bulletin, no. 43, may 2003, management of preterm labor

  19. Preterm labor • Clinical considerations • Who are appropriate candidates for intervention? • Acog practice bulletin, no. 43, may 2003, management of preterm labor

  20. Preterm labor • Clinical considerations • Are there tests that can help identify patients at risk for progressing to preterm birth? • Acog practice bulletin, no. 43, may 2003, management of preterm labor

  21. Recurrence risk of spontaneous preterm birth at <35wks according to cervical length and fetal fibronectin in women with a prior preterm birth

  22. Prediction at 22-24 wks of spontaneous preterm birth rates before 35 wks gestation, iams et al

  23. Preterm labor • Clinical considerations • Does tocolytic therapy improve neonatal outcome? • Acog practice bulletin, no. 43, may 2003, management of preterm labor

  24. Is there a clear ‘first-line’ tocolytic drug? Acog practice bulletin, no. 43, may 2003, management of preterm labor Preterm labor

  25. Preterm labor • Clinical considerations • Is there a role for adjunctive antibiotics? • Acog practice bulletin, no. 43, may 2003, management of preterm labor

  26. Preterm labor • Clinical considerations • Is preventive treatment efficacious? • Acog practice bulletin, no. 43, may 2003, management of preterm labor

  27. Preterm labor • Clinical considerations • Should women with preterm contractions without cervical change be treated? • Acog practice bulletin, no. 43, may 2003, management of preterm labor

  28. Preterm labor • Clinical considerations • Should women with multiple gestations be treated differently? • Acog practice bulletin, no. 43, may 2003, management of preterm labor

  29. Preterm labor • Clinical considerations • Is there a role for maintenance treatment after completing acute treatment? • Acog practice bulletin, no. 43, may 2003, management of preterm labor

  30. Preterm labor • Clinical considerations • Is tocolysis warranted for recurrent preterm labor? • Acog practice bulletin, no. 43, may 2003, management of preterm labor

  31. Preterm labor • Clinical considerations • Is there a role for amniocentesis? • Acog practice bulletin, no. 43, may 2003, management of preterm labor

  32. Teaching points • Examine the cervix in 2nd/3rd tri patients with symptoms • differentiate high risk from low risk • consider using fetal fibronectin and cervical length from your clinic

More Related